GLOBAL BIOENERGIES: 2016 FINANCIAL RESULTS
(Thomson Reuters ONE) -
GLOBAL BIOENERGIES: 2016 FINANCIAL RESULTS
Net loss for the Group of ?10.6 million in 2016 (vs ?10.4m in 2015)
Cash position of ?7.4 million as at 31 December 2016
Grants and structured equity agreements secure financial visibility over
2017
Evry, 4 April 2017 - Global Bioenergies (Alternext Paris: ALGBE) publishes its
2016 financial accounts, approved by the Board of Directors that took place on
this date[1].
* Group Profit & Loss as at 31 December 2016
+------------------------------------------------------------------------------+
| |
| |
|In ? thousands from 01/01/16 from 01/01/15 from 01/01/14|
| |
|GROUP CONSOLIDATED FINANCIAL to 31/12/16 to 31/12/15 to 31/12/14|
|STATEMENTS |
| |
| 12 months 12 months 12 months|
| |
| |
+------------------------------------------------------------------------------+
| |
| |
|Operating income 3,292 2,228 3,171|
| |
|Operating expenses 15,216 14,240 12,672|
| |
|Operating profit (loss) (11,924) (12,013) (9,501)|
| |
| |
| |
|Financial profit (loss) (530) (258) 130|
| |
|Exceptional profit (loss) (50) (109) (83)|
| |
| |
| |
|Income tax (1,896) (1,985) (1,876)|
| |
| |
+------------------------------------------------------------------------------+
|Net profit (loss) (10,607) (10,395) (7,578)|
+------------------------------------------------------------------------------+
The profit and loss account reflects stability from one year to another thanks
to rigorous management while the Group progressed into its industrial
development phase.
Two new partnerships - respectively with Butagaz and Aspen - generated
additional R&D revenues alongside those from historical partnerships such as
Audi.
The Group has registered a total of ?2.75 million of subsidies in 2016, thanks
to the progresses made on major projects such as the construction of the Leuna
demo plant, subsidized by the German Government, and the success of the BioMA+
project, funded by the French government.
* Group Balance Sheet as at 31 December 2016
+--------------------------------------+ +-------------------------------------+
|Assets (? thousands) 31/12/16 31/12/15| |Liabilities (? 31/12/16 31/12/15|
| | |thousands) |
+--------------------+--------+--------+ +-------------------+--------+--------+
| | | | | | | |
| | | | | | | |
|Intangible assets | 69| 106| |Capital | 168| 142|
| | | | | | | |
|Fixed assets | 12,182| 7,230| |Share premium | 49,409| 37,817|
| | | | | | | |
|Financial assets | 146| 142| |Retained earnings |(30,066)|(19,665)|
| | | | | | | |
| | | | |Profit (loss) |(10,607)|(10,395)|
| | | | | | | |
| | | | |Equipment subsidies| 391| 0|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|NON-CURRENT ASSETS | 12 397| 7,478| |EQUITY | 9,295| 7,899|
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | |PROVISIONS | 42| 30|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|Inventories - | | | |Conditional | | |
|Receivables - | 5,074| 4,313| |advances and loans | 11,483| 10,440|
|Prepaid Expenses | | | | | | |
| | | | | | | |
|Cash - Marketable | 8,066| 10,418| |Trade payables and | 4,120| 3,181|
|securities | | | |related accounts | | |
| | | | | | | |
| | | | |Other debts | 597| 660|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|CURRENT ASSETS | 13,140| 14,731| |PAYABLES | 16,200| 14,281|
| | | | | | | |
| | | |
+--------------------+--------+--------+ +-------------------+--------+--------+
|TOTAL ASSETS | 25,537| 22,209| |TOTAL LIABILITIES | 25,537| 22,209|
+--------------------+--------+--------+ +-------------------+--------+--------+
Capital investments have represented ?6.1 million in 2016, bringing total fixed
assets to
?12.2 million. These 2016 investments have been primarily directed to the Leuna
demo plant, which construction has been finished at the end of the year.
Conditional advances and loans remain stable due to the reimbursement of bank
loans on one side, and further repayable advances received from the ADEME
(BioMA+ and Isoprod projects) on the other side.
?391k of equipment subsidies have been registered in 2016, as part of the German
Ministry of Research's participation to the construction of the Leuna demo
plant.
+-------------------------------------------------------------------------+
| CASH-FLOW (? thousands) 2016 2015 2014 |
+------------------------------------------ |
| |
| |
| Operating cash-flow (9,279) (8,840) (8,009) |
| |
| Net profit (loss) (10,607) (10,395) (7,578) |
| |
| Amortization (+) 1,213 979 586 |
| |
| Gain on asset disposal (-) - - (11) |
| |
| Change in Working Capital Requirement 115 576 (1,029) |
| |
| |
| |
| Investing cash-flow (6,120) (4,488) (2,798) |
| |
| Financing cash-flow 12,676 7,873 2,720 |
| |
| |
+-------------------------------------------------------------------------+
Cash in hands as at 31 December 2016 was ?7.4 million, down by ?2.8 million over
the year. It enables the Group to cover its needs beyond the major value
creation step ahead consisting in the production of isobutene batches at the
Leuna demo plant.
* Highlights of the 2016 financial year and recent events
Industrial agreements
Historical partners Arkema and Audi both indicated that they had carried out
studies that technically validate the isobutene produced by Global Bioenergies
for paint and fuel applications, respectively.
Numerous agreements have been signed with new industrial players, demonstrating
the growing interest in the technology developed by Global Bioenergies:
* Arlanxeo, a world leader in synthetic rubber production, obtained a batch of
isobutene produced and purified from the Pomacle pilot site;
* Clariant, a European leader in speciality chemicals, purchased batches of
isobutene and validated its specifications for a specific high-value
application, which has not yet been revealed.
* in a distinct project, Clariant also produced wheat straw hydrolysate, which
was further converted into renewable isobutene at the Pomacle pilot site, a
first worldwide direct production of isobutene from "second generation"
sugars at industrial pilot scale;
* the cosmetics giant L'Oréal is moving closer to its aim of using biosourced
ingredients with its involvement in a new project that has received ?9
million from the Investissements d'Avenir French public financing program.
The project also brings together the sugar group Cristal Union, Global
Bioenergies and their jointly held subsidiary IBN-One;
* the Swedish group Aspen secured access rights to isooctane made from
isobutene that will be produced at Leuna and by IBN-One for a speciality
fuels application (alkylate gasoline for small two- and four-stroke
engines);
* Butagaz will become the first gas distributor in France to market butane and
propane containing bio-isobutene, in an exclusive partnership with Global
Bioenergies. The first batches of bio-isobutene would be incorporated in
2017. Butagaz will contribute financially to Global Bioenergies' industrial
development, in return for reserved batches of isobutene produced at the
Leuna demo plant.
* Preem, Sekab and Sveaskog, three Swedish companies that, with support from
the Swedish Energy Agency, have joined forces to develop a high-performance
fuel entirely based on forest resources, selected Global Bioenergies to
complete their consortium. The value chain will rely on Sveaskog's forestry
activities, Sekab's biomass to sugar conversion process, Global Bioenergies
Isobutene process and Preem's gasoline production processes, blending and
retail activities.
Construction of the demo plant at Leuna is finished
At the beginning of June, the Group reported that all of the demo plant's large
units had been received. The last construction phase consisted in connecting the
different units together and realizing the complete audit prerequisite to
receiving the operating permit. In December, the operations were started at the
Demo plant.
Acquisition of Syngip B.V.
In February 2017, Global Bioenergies finalized the acquisition of Syngip B.V., a
start-up based in the Netherlands specialized in converting third-generation
resources into fuels and materials. This acquisition is central to Global
Bioenergies' strategy of diversifying the feedstocks suitable for use in its
Isobutene process.
François-Henri Reynaud, Global Bioenergies Chief Financial Officer, comments:
"Great steps have been made in 2016 which, from a financial standpoint, required
careful attention. Thanks to rigorous management of our operational and capital
expenses, along with the scheduled investments from Bracknor, we took up the
challenges with confidence."
Marc Delcourt, co-founder and CEO at Global Bioenergies, concludes: "Proving our
capabilities to take care of large industrial projects such as the Leuna Demo
plant has raised a lot of attention in the industrial community and led to the
signature of numerous agreements with industrialists from different fields. We
expect to intensify these business successes in 2017."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in
Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its efforts on
the production of isobutene, one of the most important petrochemical building
blocks that can be converted into fuels, plastics, organic glass and elastomers.
Global Bioenergies continues to improve the performance of its process, operates
an industrial pilot, has started operations at its demo plant in Germany, and is
preparing its first full-scale plant through a joint venture with Cristal Union,
named IBN-One. The company also replicated its achievement to propylene and
butadiene, two members of the gaseous olefins family, key molecules at the heart
of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext
Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: (at)GlobalBioenergi
Contact
GLOBAL BIOENERGIES
François-Henri REYNAUD
Chief Financial Officer
Phone: +33 1 64 98 20 50
Email: invest(at)global-bioenergies.com
--------------------------------------------------------------------------------
[1] The annual report 2016 will be available on the website by the end of April
2017.
GLOBAL BIOENERGIES - Press release:
http://hugin.info/166909/R/2093608/791487.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBAL BIOENERGIES via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 04.04.2017 - 17:37 Uhr
Sprache: Deutsch
News-ID 534451
Anzahl Zeichen: 17880
contact information:
Town:
Evry
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GLOBAL BIOENERGIES: 2016 FINANCIAL RESULTS"
steht unter der journalistisch-redaktionellen Verantwortung von
GLOBAL BIOENERGIES (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
